Processes for preparing...

Details Processes for preparing... Processes for preparing...

2008-05-27

2008-05-27

Desai, Rita (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S108000

Reexamination Certificate

active

07378427

ABSTRACT:
Synthetic methods are provided for production of compounds of the formula:where R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13and R14are as defined in the specification.

REFERENCES:
patent: 5326875 (1994-07-01), Talaga et al.
patent: 5476942 (1995-12-01), Lassalle et al.
patent: 5552410 (1996-09-01), Galtier et al.
patent: 5703244 (1997-12-01), Li et al.
patent: 5786496 (1998-07-01), O'Halloran et al.
patent: 2003/0096019 (2003-05-01), Currie et al.
patent: 2005/0113405 (2005-05-01), Harnish et al.
patent: 0 428 365 (1991-05-01), None
patent: 0 496 393 (1995-01-01), None
patent: 0 643 046 (1995-03-01), None
patent: 0 643 047 (1995-03-01), None
patent: 1 002 794 (2000-05-01), None
patent: 2710067 (1995-03-01), None
patent: 05170725 (1993-07-01), None
patent: 08092082 (1996-04-01), None
patent: 2564141 (1996-12-01), None
patent: 2000026476 (2000-01-01), None
patent: 2000038387 (2000-02-01), None
patent: 9509521 (1995-08-01), None
patent: 93/21149 (1993-10-01), None
patent: 95/16682 (1995-06-01), None
patent: 95/31438 (1995-11-01), None
patent: 96/26223 (1996-08-01), None
patent: 98/10761 (1998-03-01), None
patent: 98/11108 (1998-03-01), None
patent: 00/40561 (2000-07-01), None
patent: 00/77010 (2000-12-01), None
patent: 01/21602 (2001-03-01), None
patent: 01/55085 (2001-08-01), None
patent: 01/70228 (2001-09-01), None
patent: 2004/050631 (2004-06-01), None
patent: WO 2005 039581 (2005-05-01), None
patent: WO 2005 039582 (2005-05-01), None
patent: WO 2005 039583 (2005-05-01), None
Ostendorf, M. et al, Eur. J. Org. Chem. 200, 105-113.
Corey, E.J. et al, Journal of the American Chemical Society, 1987, 109, 7925-7926.
Giannis, A. et al, Angew. Chem. Int. Ed. Engl, 1989, 28, 218-220.
Adams, M. R. et al., “Inhibition of Coronary Artery Atherosclerosis by 17-beta Estradiol in Ovariectomized Monkeys,”Arterio., 1990, 10(6),1051-1057.
Alexander et. al., “Initiation of Hormone Replacement Therapy After Acute Myocardial Infarction Is Associated With More Cardiac Events During Follow-Up,”J. Am. Coll. Cardio., 2001, 38, 1-7.
Bauer M. A., Herrmann F., “Interleukin-6 in clinical medicine,”Ann. Hematol., 1991, 62, 203-210.
Cefalu, W., “The Use of Hormone Replacement Therapy in Postmenopausal Women with Type 2 Diabetes,”J Womens Health&Gender-based Med., 2001, 10(3), 241-255.
Cercek, B. et al., “Nuclear factor-κB Activity and arterial response to balloon injury,”Atherosclerosis131, 59-66 (1997).
Chandrasekar, B. et al. “Ischemia-Reperfusion of Rat Myocardium Activates Nuclear Factor- κB and Induces Neutrophil Infiltration Via Lipopolysaccharide-Induced CXC Chemokine,”Circulation103, 2296-2302 (2001).
Lin, Chin-Chi et.al., “Pulmonary function changes and increased Th-2 cytokine expression and nuclear factor kB activation in the lung after sensitization and allergen challenge in brown Norway rats,”Immunol. Lett., 2000, 73, 57-64.
Delyani, J. A. et al., “Protection from Myocardial Reperfusion Injury by Acute Administration of 17 β-Estradiol,”J. Molec. Cell. Cardiol., 1996, 28, 1001-1008.
Dietrich, H. et al., “Mouse Model of Transplant Arteriosclerosis,”Arterioscler. Thromb. Vasc. Biol. 20, 343-352 (2000).
Dubal et al., “Estradiol Modulates bcl-2 in Cerebral Ischemia: A Potential Role for Estrogen Receptors,”Journal of Neuroscience, 1999, 19, 6385-6393.
Dubal et al., “Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury,”Proceedings of the National Academy of Sciences of the United States of America, 2001, 98(4), 1952-1957.
Felson, D. T. et al., “The effects of estrogen on osteoarthritis,”Curr Opinion Rheum, 1998, 10, 269-272.
Grigg, R. et al., “Phenanthrene type heterocycles via Rh(I) catalysed [2+2+2]-cycloaddition and Pd(0) catalysed arylation”Tetrahedron Lett, 2000, 41(16), 3003-3006.
Grigg, R. et al., “Palladium Catalysed Intramolecular Coupling of Aryl and Benzylic Halides and Related Tandem Cyclisations. A Simple Synthesis of Hippadine”,Tetrahedron Lett, 1991, 32(31), 3859-3862.
Grigg, R. et al., “Palladium Catalysed Triscyclisation-Anion Capture Queuing Cascades,”Tetrahedron Lett, 1997, 38(10), 1825-1828.
Grodstein F. et. al., “Postmenopausal Hormone Use and Secondary Prevention of Coronary Events in the Nurses' Health Study,”Ann. Int. Med, 2001, 135,1-8.
Grodstein, F. et. al., “A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease,”Ann. Int. Med., 2000, 133, 933-41.
Heck, R.F., “Palladium-Catalyzed Reactions of Organic Halides with Olefins,”Acc Chem Res, 1979, 12(4), 146-151.
Hulley, S. et. al., “Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women,”J. Am. Med. Assoc., 1998, 280, 605-13.
Izumi, T. et al., “Blockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-κB activation and alleviation myocardial ischemia/reperfusion injury,”J. Clin. Invest, 108, 203-213 (2001).
Kant, J., et al., “Reissert Compound Studies . XLV. The Phenanthridine Reissert Compound,”J Heterocycl Chem, 1984, 21(2), 425-427.
Karas, R. H. et al., “Effects of Estrogen on the Vascular Injury Response in Estrogen Receptor α,β (Double) Knockout Mice,”Circ. Res. 89, 534-539 (2001).
Kurebayashi S. et. al., “Characterization of Mechanisms of Interleukin-6 Gene Repression by Estrogen Receptor,”J. Steroid Biochem. Molec. Biol., 1997, 60, 11-17.
Lou, H. et al., “Inhibition of Transplant Coronary Arteriosclerosis in Rabbits by Chronic Estradiol Treatment Is Associated With Abolition of MHC Class II Antigen Expression,”Circulation94, 3355-3361 (1996).
Lundeen et al., “Rat uterine Complement C3 expression as a model for progesterone receptor modulators: characterization of a new progesterin trimegestone,”J Steroid Biochem Mol Biol, 2001, 78, 137-143.
Mankin, et al., “Biochemical and Metabolic Abnormalities in Articular Cartilage from Osteo-Arthritic Human Hips,”Journal of Bone&Joint Surgery—American, 1971, 53, 523-537.
Merchenthaler, et al., “The effect of estrogens and antiestrogens in a rat model for hot flush,”Maturitas,1998, 30, 307-316.
Miura, M. et al., “Oxidative Cross-Coupling of N-(2′-Phenylphenyl) benzenesulfonamides of Benzoic and Naphthoic Acids with Alkenes Using a Palladium-Copper Catalyst System under Air,”J Org Chem, 1998, 63(15), 5211-5215.
Nathan, L. et. al., “Estradiol Inhibits Leukocyte Adhesion and Transendothelial Migration in Rabbits In Vivo,”Circ. Res., 1999, 85, 377-385.
Patra, P.K. et al., “A New Regiospecific Method for the Synthesis of Substituted Phenanthridines and Benzo[j]phenanthridines via Aromatic ]- Annelation of 1-N-Benzenesulfonyl-3-[Bis(methylthio)methylene 1,2,3,4-tetrahydroquinoline-4-one,”Tetrahedron, 1998, 54(34), 10167-10178.
Pelletier et al., “Osteoarthritis, an Inflammatory Disease,”Arthr.&Rheum., 2001, 44, 1237-1247.
Poole and Coombs, “Rheumatoid-Like Joint Lesions in Rabbits Injected Intravenously with Bovine Serum,”International Archives of Allergy&Applied Immunology, 1977, 54, 97-113.
Reis et. al., “Estrogen Is Associated With Improved Survival in Aging Women With Congestive Heart Failure: Analysis of the Vesnarinone Studies,”J. Am. Coll. Cardio., 2000, 36, 529-33.
Shugrue et al., “Regulation of Progesterone Receptor Messenger Ribonucleic Acid in the Rat Medial Preoptic Nucleus by Estrogenic and Antiestrogenic Compounds: An in Situ Hybridization Study,”Endocrinology, 1997, 138, 5476-5484.
Smirnoff, P. et al., “The Protective Effect of Estrogen Against Chemically Induced Murine Colon Carcinogenesis Is Associated With Decreased CpG

Affiliated with

Also associated with

Rating

Processes for preparing... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Processes for preparing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Processes for preparing... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2776883